All Essays

Defining Government Failure

Defining Government Failure

Ideological presumptions should not obscure key elements of “government failure.”

Tax Administration and the “Force of Law”

Tax Administration and the “Force of Law”

Current tax administration reveals agencies’ muddled application of “force of law” determinations.

Week in Review

Week in Review

Supreme Court allows FTC continue suit, SEC may seek admissions of guilt, and more…

We the People of the Internet

We the People of the Internet

White House website collects and responds to public petitions.

A Call to Clarify the Regulatory Scope of Money Transmitter Laws

A Call to Clarify the Regulatory Scope of Money Transmitter Laws

The scope of state law threatens the viability of new payment systems.

CMS Proposes to Significantly Increase Reward for Reporting Medicare Fraud

CMS Proposes to Significantly Increase Reward for Reporting Medicare Fraud

CMS expects proposed rule to help recuperate more Medicare funds.

Transforming the Nature of Drug Safety Regulation

Transforming the Nature of Drug Safety Regulation

Using retrospective drug safety data can improve patient care.

Senators Question President’s Pick for OIRA Administrator

Senators Question President’s Pick for OIRA Administrator

Howard Shelanski questioned on delays, retrospective review, and role for cost-benefit analysis.

Week in Review

Week in Review

Confirmation hearing for OIRA nominee, Supreme Court takings decision, CFPB offers exemptions, and more…

Using a Compliance Cost Cap to Constrain Regulation

Using a Compliance Cost Cap to Constrain Regulation

Forthcoming paper proposes firm limits be set on costs of regulatory policy.

TSA Seeks Comments on Whole Body Imaging at Airports

TSA Seeks Comments on Whole Body Imaging at Airports

TSA will install new privacy technology on screening machines in coming weeks.

FTC Report Shows Increase in Pay-for-Delay Drug Settlements

FTC Report Shows Increase in Pay-for-Delay Drug Settlements

Agency report indicates that potentially anti-competitive drug settlements are on the rise.